Post Oscillate and Oscar, demonstrating no improvement in survival with HFOV, should we be considering extracorporeal support more often in ARDS?

Were you surprised by the two studies published in the NEJM, Oscar and Oscillate? Is the benefit of HFOV lost in the era of low volume, pressure limited ventilation for ARDS? Will you continue...

29 January 2013 9,256 9 View